Hematology / Oncology @Point of Care Podcasts artwork

S18:E2 – Morning Commute Podcast: Embracing HER2-Low, Trop2-Directed, and Other Newer Approaches to HR-Positive Breast Cancer

Hematology / Oncology @Point of Care Podcasts

English - November 30, 2023 16:59 - 30 minutes - 41.3 MB
Medicine Health & Fitness checkpointinhibitors cmece endometrialcancer immunotherapy Homepage Download Google Podcasts Overcast Castro Pocket Casts RSS feed
Previous Episode: S18:E1 – Morning Commute Podcast: An AKTor and Supporting Cast Take the Stage in HR+ Breast Cancer
Next Episode: S18:E3 – Morning Commute Podcast: Biomarker Testing in HR+ Breast Cancer—If the Shoe Fits

In this podcast, our faculty take a look at some of the clinical data behind the newer treatment strategies for HR-positive breast cancer as well as how to address and manage some associated adverse events.


Visit www.morningcommutepodcast.com/HRPositiveBreast2 to view the activity and CME/CE information, download the transcript, and complete the post-test and evaluation to earn CME/CE credit.